AtriCure (ATRC) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 18, 2026, to be held virtually for shareholder participation.

• Proxy materials, including the proxy statement and annual report, are available online for review prior to voting.

• Shareholders can vote online, by phone, by mail, or during the virtual meeting.

Voting matters and shareholder proposals

• Election of nine directors: Michael H. Carrel, Regina E. Groves, B. Kristine Johnson, Shlomo Nachman, Karen N. Prange, Deborah H. Telman, Sven A. Wehrwein, Robert S. White, and Maggie Yuen.

• Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Approval of amendment to the 2023 Stock Incentive Plan to increase authorized shares by 1,500,000.

• Approval of amendment to the 2018 Employee Stock Purchase Plan to increase authorized shares by 750,000.

• Advisory vote on executive compensation as disclosed in the proxy statement.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and all proposals.

• Proxy holders are authorized to vote on other business as may properly come before the meeting.